MDSpire - Summary
From the Journals

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

Share

Recent efforts aim to accurately define painful temporomandibular disorders (TMDs) for inclusion in Global Burden of Disease estimates, acknowledging that TMDs affect 10% of adults and diminish quality of life. Researchers, guided by experts, developed a lay description through structured consensus involving clinicians and patient representatives. This comprehensive approach prioritized symptom details, severity classifications, and associated comorbidities. The authors stress that enhancing disability assessments is crucial for a more reliable measure of TMD's health impact.

Original Source(s)

Researchers Propose TMD Definition for GBD

  • by Kathryn Wighton

  • March 23, 2026

Related Content

Tau Biomarker Expands Beyond Alzheimer’s

Study finds elevated phosphorylated tau in AL and ATTR amyloidosis, suggesting a potential blood biomarker for amyloid-related neuropathy

  • March 25, 2026

  • 3 min
CAR-Engineered Astrocytes in Alzheimer’s Models

Preclinical findings show engineered astrocytes reduce amyloid buildup in mouse models and demonstrate a potential therapeutic approach

  • March 25, 2026

  • 2 min
ALS Trial Tests Celecoxib–Ciprofloxacin Combination

Dual-drug therapy showed signals of slower disease progression and reduced complications in patients with ALS.